Table 1.
Factors | Subgroup | n | p value | 5-y ORN rate (%) |
---|---|---|---|---|
V10 |
<14.5 ml |
31 |
|
26.1 |
|
≥14.5 ml |
32 |
0.015 |
53 |
V20 |
<11.9 ml |
31 |
|
20 |
|
≥11.9 ml |
32 |
0.001 |
58.5 |
V30 |
<8.1 ml |
31 |
|
13.7 |
|
≥8.1 ml |
32 |
0.001 |
64.4 |
V40 |
<4.6 ml |
31 |
|
12.1 |
|
≥4.6 ml |
32 |
0.0002 |
67.7 |
V50 |
<3.0 ml |
31 |
|
11.7 |
|
≥3.0 ml |
32 |
0.0002 |
69.5 |
Age (years) |
<59 |
31 |
|
33.5 |
|
≥59 |
32 |
0.23 |
45.5 |
Sex |
Male |
31 |
|
40.4 |
|
Female |
32 |
0.5 |
38.2 |
Teeth in the PTV |
None |
34 |
|
5.9 |
|
Some |
29 |
0.0001 |
81 |
Smoking |
Yes |
22 |
|
41.6 |
|
No |
41 |
0.66 |
38.6 |
Alcohol |
Yes |
31 |
|
48.6 |
|
No |
32 |
0.11 |
30.3 |
Chemotherapy |
Yes |
23 |
|
54.0 |
No | 40 | 0.04 | 30.5 |
A large V10 to V50 and the presence of teeth within the PTV were found to correlate with ORN development.